Clinical study
Cardiac manifestations in polymyositis

https://doi.org/10.1016/0002-9149(78)90871-8Get rights and content

Abstract

Twenty-one patients with polymyositis were prospectively examined with echocardiography, phonocardiography and electrocardiography. Cardiac performance, estimated with echocardiography, was enhanced, as shown by a significant (P < 0.01) increase In ejection phase indexes of left ventricular function compared with values in a matched control group. Known causes of the high output state, such as anemia or thyrotoxicosis, were not clinically evident. There was no evidence of left ventricular enlargement, left ventricular wall hypertrophy, or left atrial enlargement in the echocardlogram or chest X-ray film. The echocardiogram showed systolic mitral valve prolapse in 11 of 17 patients (65 percent) with an adequately imaged mitral valve; midsystolic cllcks were present in 7 of these. One patient, who did not have prolapse, had echocardiographic evidence of a small pericardial effusion. Electrocardiographic abnormalities were present in 11 of 21 patients (52 percent) and included evidence of atrioventricular conduction disturbances, atrial and ventricular arrhythmias and left atrial abnormality.

The pathophysiology of mitral valve prolapse and increased systolic left ventricular function in polymyositis remains uncertain; however, the spectrum of cardiac abnormalities, detected noninvasively in 16 of 21 of our patients (76 percent) may represent a high frequency rate of cardiac involvement in this disease.

References (39)

  • L Fernandez-Herlihy

    Heart block in polymyositis

    N Engl J Med

    (1971)
  • PG Lynch

    Cardiac involvement in chronic polymyositis

    Br Heart J

    (1971)
  • GR Diessner et al.

    Laboratory tests in polymyositis

    Arch Intern Med

    (1966)
  • WC Manion

    Myocarditis

    Arch Pathol

    (1956)
  • DL Hill et al.

    Identical skeletal and cardiac muscle involvement in a case of fatal polymyositis

    Arch Neurol

    (1968)
  • RK Winkelmann et al.

    Course of dermatomyositis-polymyositis: comparison of untreated and cortisone treated patients

    Mayo Clin Proc

    (1968)
  • C Sheard

    Dermatomyositis

    Arch Intern Med

    (1951)
  • JN Walton et al.

    Polymyositis

  • B Duperrat et al.

    Dermatomyosite avec localisation cardiaque

    Bull Soc Fr Derm Syph

    (1972)
  • Cited by (119)

    • Dermatomyositis and Polymyositis

      2017, The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches
    • Electrocardiographic changes in dermatomyositis and polymyositis

      2016, Revista Brasileira de Reumatologia
      Citation Excerpt :

      So far, there are few studies evaluating electrocardiographic changes in patients with DM and PM; and, when present, these are limited to a small number of cases and/or in the absence of a control group,7,9,10,12,13 differently of the present study. ECG changes in idiopathic inflammatory myopathies occur in 33–72%.3–5,7–13 Our data show that LVH was significantly present in patients with DM and PM compared to the control group.

    View all citing articles on Scopus
    View full text